Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

3 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials
NCT05179863Recruiting

Swiss Rare Disease Registry (SRDR)

Role: collaborator

NCT07204860Completed

menuCH-Kids, the First Swiss National Nutrition Survey in Children and Adolescents

Role: collaborator

NCT05017142Recruiting

Swiss Pediatric Inflammatory Brain Disease Registry (Swiss-Ped-IBrainD)

Role: collaborator

NCT04442685Completed

The Swiss Registry for Heart Diseases in Children Living in Switzerland. SPHC

Role: collaborator

NCT05606588Not ApplicableRecruiting

Preventing Sensory and Motor Dysfunctions in Children Receiving Neurotoxic Chemotherapy

Role: collaborator

NCT04043325Unknown

Diagnosis of Mycoplasma Pneumoniae Infection With Detection of Specific Antibody-secreting Cells in Community-acquired Pneumonia (CAP) Patients of the Randomised Placebo-controlled Multi-centre Effectiveness Trial of Adjunct Betamethasone Therapy

Role: collaborator

NCT03270423Not ApplicableCompleted

PathMate2: The Impact of Health Information System Services on the Effects of Therapy in Overweight Teenagers

Role: lead

NCT03233425Completed

Evaluation of Multiprofessional Group Programs for Paediatric Obesity Therapy

Role: lead

All 8 trials loaded